Zone7, a Palo Alto, Calif.—based artificial intelligence driven platform to predict injuries in sports, raised $2.5m in seed funding.
The round was led by Resolute Ventures, with participation from UpWest, Amicus Capital, Dave Pell, PLG Ventures, as well as current and former professional athletes.
Co-founded by CEO Tal Brown and CTO Eyal Eliakim, Zone7 provides an AI-powered injury prevention intelligence prediction platform which has logged more than 5 million hours of athlete performance, and is already being used by teams in the MLB, La Liga, Champions League, MLS, collegiate athletic departments and Olympic teams to prolong the careers of their players.
The platform connects automatically to medical and athlete performance data, without requiring any new hardware or data entry for the team. The proprietary AI then creates a customized pattern recognition model for each athlete on the team to identify injury risk and enable coaches to provide training and game intervention strategies resulting in reduced injury rates. Actionable recommendations are sent directly to personal mobile devices so coaches, athletic trainers, and doctors can make informed decisions on the field.